Advertisement
ASMB vs EPRX
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASMB is a StrongBuy and EPRX is a Buy.
ASMB's RSI Indicator climbs out of oversold territory
The RSI Indicator for ASMB moved out of oversold territory on October 27, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 31 similar instances when the indicator left oversold territory. In 26 of the 31 cases the stock moved higher. This puts the odds of a move higher at 84%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on ASMB as a result. In 76 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.
The Moving Average Convergence Divergence (MACD) for ASMB just turned positive on October 20, 2026. Looking at past instances where ASMB's MACD turned positive, the stock continued to rise in 34 of 42 cases over the following month. The odds of a continued upward trend are 81%.
Following a +8.95% 3-day Advance, the price is estimated to grow further. Considering data from situations where ASMB advanced for three days, in 215 of 267 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The 50-day moving average for ASMB moved below the 200-day moving average on October 23, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ASMB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
ASMB broke above its upper Bollinger Band on November 11, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ASMB entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 75 (best 1 - 100 worst), indicating slightly worse than average price growth. ASMB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 84 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.360) is normal, around the industry mean (3.498). P/E Ratio (16.468) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (5.568) is also within normal values, averaging (440.869).
The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ASMB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
EPRX in +8.62% Uptrend, advancing for three consecutive days on November 11, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where EPRX advanced for three days, in 101 of 125 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on EPRX as a result. In 66 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 78%.
The Moving Average Convergence Divergence (MACD) for EPRX just turned positive on November 09, 2026. Looking at past instances where EPRX's MACD turned positive, the stock continued to rise in 29 of 39 cases over the following month. The odds of a continued upward trend are 74%.
EPRX moved above its 50-day moving average on November 10, 2026 date and that indicates a change from a downward trend to an upward trend.
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The 10-day moving average for EPRX crossed bearishly below the 50-day moving average on October 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 17 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EPRX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
EPRX broke above its upper Bollinger Band on November 11, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for EPRX entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 26 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.213) is normal, around the industry mean (3.498). P/E Ratio (-6.755) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).
The Tickeron Profit vs. Risk Rating rating for this company is 34 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. EPRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 59 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
ASMB | ||
|---|---|---|
OUTLOOK RATING 1..100 | 32 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 84 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 89 | |
PRICE GROWTH RATING 1..100 | 75 | |
P/E GROWTH RATING 1..100 | 97 | |
SEASONALITY SCORE 1..100 | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| ASMB | EPRX | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 84% | N/A |
| Stochastic ODDS (%) | 1 day ago 76% | 1 day ago 77% |
| Momentum ODDS (%) | 1 day ago 80% | 1 day ago 78% |
| MACD ODDS (%) | 1 day ago 81% | 1 day ago 74% |
| TrendWeek ODDS (%) | 1 day ago 82% | 1 day ago 54% |
| TrendMonth ODDS (%) | 1 day ago 83% | 1 day ago 54% |
| Advances ODDS (%) | 3 days ago 81% | 1 day ago 81% |
| Declines ODDS (%) | 10 days ago 86% | 7 days ago 74% |
| BollingerBands ODDS (%) | 1 day ago 84% | 1 day ago 79% |
| Aroon ODDS (%) | 1 day ago 87% | 1 day ago 51% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ASMB’s FA Score shows that 0 FA rating(s) are green while EPRX’s FA Score has 1 green FA rating(s).
- ASMB’s FA Score: 0 green, 5 red.
- EPRX’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ASMB’s TA Score shows that 4 TA indicator(s) are bullish while EPRX’s TA Score has 4 bullish TA indicator(s).
- ASMB’s TA Score: 4 bullish, 5 bearish.
- EPRX’s TA Score: 4 bullish, 5 bearish.
Price Growth
ASMB (@Biotechnology) experienced а +12.58% price change this week, while EPRX (@Biotechnology) price change was +19.23% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -0.49%. For the same industry, the average monthly price growth was -6.84%, and the average quarterly price growth was -13.86%.
Reported Earning Dates
ASMB is expected to report earnings on Mar 25, 2027.
EPRX is expected to report earnings on Mar 30, 2027.
Industries' Descriptions
@Biotechnology (-0.49% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
ASMB and
Correlation & Price change
A.I.dvisor indicates that over the last year, ASMB has been loosely correlated with ENTA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ASMB jumps, then ENTA could also see price increases.
| Ticker / NAME | Correlation To ASMB | 1D Price Change % | ||
|---|---|---|---|---|
| ASMB | 100% | +4.78% | ||
| ENTA - ASMB | 44% Loosely correlated | +3.39% | ||
| EDIT - ASMB | 44% Loosely correlated | -4.99% | ||
| VYGR - ASMB | 43% Loosely correlated | -3.56% | ||
| IMMX - ASMB | 43% Loosely correlated | +3.71% | ||
| FDMT - ASMB | 42% Loosely correlated | +4.25% | ||
More | ||||
EPRX and
Correlation & Price change
A.I.dvisor indicates that over the last year, EPRX has been loosely correlated with TARS. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if EPRX jumps, then TARS could also see price increases.
| Ticker / NAME | Correlation To EPRX | 1D Price Change % | ||
|---|---|---|---|---|
| EPRX | 100% | +5.64% | ||
| TARS - EPRX | 38% Loosely correlated | +3.97% | ||
| ASMB - EPRX | 37% Loosely correlated | +4.78% | ||
| MLYS - EPRX | 36% Loosely correlated | +4.12% | ||
| NAMS - EPRX | 36% Loosely correlated | +8.03% | ||
| SGMT - EPRX | 36% Loosely correlated | +4.78% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| CRYPTO / NAME | Price $ | Chg $ | Chg % |
| NULS.X | 0.003596 | N/A | +0.01% |
| NULS cryptocurrency | |||
| BNB.X | 679.505250 | -0.085632 | -0.01% |
| BNB cryptocurrency | |||
| OG.X | 2.087567 | -0.017201 | -0.82% |
| OG Fan Token cryptocurrency | |||
| TWT.X | 0.386293 | -0.005318 | -1.36% |
| Trust Wallet Token cryptocurrency | |||
| PHA.X | 0.033412 | -0.001278 | -3.68% |
| Phala Network cryptocurrency | |||